Results 61 to 70 of about 36,142 (215)

Intestinal Atresia in Finland: Maternal Risk Factors, Prevalence, Associated Anomalies and Survival

Acta Paediatrica, EarlyView.
ABSTRACT Aim We aimed to investigate prevalence, associated anomalies and survival of congenital intestinal atresia and to examine maternal risk factors for jejunoileal atresia (JIA). Methods All children born with, or pregnancies terminated because of, JIA or colonic atresia (CA) in Finland during 1987–2019 were identified from the Finnish Register of
Esko Tahkola, Arimatias Raitio, Ilkka Helenius, Johanna Syvänen, Teemu Kemppainen, Eliisa Löyttyniemi, Maarit K. Leinonen, Mika Gissler, Topi Luoto, Mikko P. Pakarinen   +9 more
wiley   +1 more source

Identification of delivery models for the provision of predictive genetic testing in Europe: protocol for a multicentre qualitative study and a systematic review of the literature [PDF]

, 2017
Introduction: The appropriate application of genomic technologies in healthcare is surrounded by many concerns. In particular, there is a lack of evidence on what constitutes an optimal genetic service delivery model, which depends on the type of genetic
Adamo, Giovanna, D'Andrea, Elvira, DE VITO, Corrado, Lagerberg, Tyra Brita Margareta, Marzuillo, Carolina, Pitini, Erica, Rosso, Annalisa, Unim, BRIGID ANDOUNIMYE, Vacchio, Maria Rosaria, Villari, Paolo   +9 more
core   +2 more sources

The role of low molecular weight heparin in women with hereditary thrombophilia for good perinatal outcome

Acta Clinica Croatica, 2016
The aim of the study was to establish the importance of low molecular weight heparin (LMWH) treatment for good pregnancy outcome in patients with hereditary thrombophilia.
Vesna Sokol, Marina Ivanišević, Mislav Herman, Josip Đelmiš   +3 more
doaj   +1 more source

ABO Blood Groups and Thrombophilia Markers in Patients With Unstimulated Thrombosis in Kurdistan Region of Iraq

Clinical and Applied Thrombosis/Hemostasis, 2020
Thromboembolism (TE) is a complex disease caused by various acquired and inherited factors. The common mutations; factor V Leiden G1691A (FVL G1691A), prothrombin G20210A (PTG20210A), and methylene tetrahydrofolate reductase C677T (MTHFR C677T) are ...
Ali Ibrahim Mohammed MD, FICMS, Aveen M. Raouf Abdulqader MD, PhD, Sana Dlawar Jalal MD, FICMS, Sarwar Noori Mahmood MD, FICMS, FEBU   +3 more
doaj   +1 more source

Assessment of the Particularities of Thrombophilia in the Management of Pregnant Women in the Western Part of Romania

Medicina, 2023
Background and objectives: Thrombophilia in pregnant women is a condition whose incidence is constantly increasing worldwide, and, under these conditions, the development of preventive procedures is becoming essential. In this study, we aimed to evaluate
Miruna Samfireag, Cristina Potre, Ovidiu Potre, Lavinia-Cristina Moleriu, Izabella Petre, Ema Borsi, Teodora Hoinoiu, Marius Preda, Tudor-Alexandru Popoiu, Andrei Anghel   +9 more
doaj   +1 more source

Factor V Leiden and Prothrombin G20210A in Portuguese Women with Recurrent Miscarriage: Is it Worthwhile to Investigate? [PDF]

, 2011
OBJECTIVE: To compare the prevalence of factor V Leiden (FVL) and prothrombin (PT) G20210A mutations in Portuguese women with unexplained recurrent miscarriage (RM) and a control group of parous women.
Almeida, JP, Branco, J, Lima, ML, Lopes, C, Serrano, F   +4 more
core   +2 more sources

Thrombophilia in women undergoing medically assisted reproduction – prevalence and clinical consequence

Thrombosis Update
Introduction: In Denmark, 10 % of new-borns are being conceived with the aid of medically assisted reproduction (MAR). MAR can imply induction of high levels of oestradiol, which in turn leads to increased coagulation activity, decreased natural ...
Jesper Strandberg, Anne-Mette Hvas, Jurgita Janukonyté, Søren Risom Kristensen, Ulrik Schiøler Kesmodel, Anette Tarp Hansen   +5 more
doaj   +1 more source

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

Clinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Guidelines on fibrinogen assays [PDF]

, 2003
No abstract ...
Becker, Blanco, Blomback, Cambas, Chantarangkul, Chantarangkul, Chitolie, Chitolie, Clauss, Cremer, Cushman, De Cristofaro, De Maat, De Metz, Eliasson, Gaffney, Gordon D. O. Lowe, Hantgan, Haverkate, Hoffmann, Humphries, Ian J. Mackie, Jacobsson, Kitchen, Kluft, Lawrie, Lowe, Lowe, Ludlam, Machin, Mackie, Marder, MDA, MDA, Natelson, NCCLS, Nieuwenhuizen, Oosting, Palareti, Rampling, Ratnoff, Rosenson, Rossi, Samuel J. Machin, Steven Kitchen, Swain, Sweetnam, Sweetnam, Thompson, Van Der Bom, Vermylen, Whicher, World Health Organisation Report   +52 more
core   +1 more source

Postpartum maternal thrombophilia workup value in pregnancies with severe small for gestational age

Acta Obstetricia et Gynecologica Scandinavica
Introduction In the absence of prenatal etiology explaining small for gestational age (SGA), a blood workup may be performed postpartum to look for maternal thrombophilia if a newborn is confirmed to be growth‐restricted at birth.
Maëlig Abgral, Céline Desconclois, Sophie Prevot, Isabelle Monier, Raluca Sterpu, Alexandra Benachi, Alexandre J. Vivanti   +6 more
doaj   +1 more source